Prevalence of Anxiety May Not be Elevated in Thai Ovarian Cancer Patients Following Treatment

  • Chittrakul, Saranya (Department of Obstetrics and Gynecology, Department of Psychiatry, Faculty of Medicine, Chiang Mai University) ;
  • Charoenkwan, Kittipat (Department of Obstetrics and Gynecology, Department of Psychiatry, Faculty of Medicine, Chiang Mai University) ;
  • Wongpakaran, Nahathai (Department of Obstetrics and Gynecology, Department of Psychiatry, Faculty of Medicine, Chiang Mai University)
  • Published : 2015.03.04


Background: To compare prevalence of anxiety in ovarian cancer patients following primary treatment to that of normal women and to examine predicting factor. Materials and Methods: In this cross-sectional study, 56 ovarian cancer patients who had primary surgical treatment within the past five years (cancer group) and 56 age-matched women who attended an outpatient clinic for check-ups (non-cancer group) were recruited from June 2013 to January 2014. The hospital anxiety and depression scale (HADS), was used to determine anxiety level of the participants with the score of ${\geq}11$ suggestive of anxiety. The prevalence of anxiety symptoms and mean HADS scores for anxiety were compared between the study groups. For those with ovarian cancer, associations of demographic and clinical factors with anxiety was examined. A p-value of <0.05 was considered significant. Results: Participants in the non-cancer group had higher rate of medical comorbidity, higher salary, and more frequent university education. The prevalence of anxiety was not different between the groups, at 7.1% each. The mean HADS scores for anxiety subscale were not significantly different between the groups, 5.0 in the cancer group vs 6.1 in the non-cancer group (p=0.09). On multivariable analysis, no demographic or clinical factors significantly associated with anxiety were identified. For the cancer group, no association between any particular factors and anxiety was demonstrated. Conclusions: The prevalence of anxiety in women with ovarian cancer following primary treatment was comparable to that of normal women seeking routine check-up.


Supported by : Higher Education Commission


  1. Akkuzu G (2012). Quality of life of women undergoing chemotherapy for a gynaecological oncological disease in Turkey. Asian Pac J Cancer Prev, 13, 1277-80.
  2. Akkuzu G, Ayhan A (2013). Sexual functions of Turkish women with gynecologic cancer during the chemotherapy process. Asian Pac J Cancer Prev, 14, 3561-4.
  3. Akkuzu G, Talas MS, Ortac F (2014). Functional status in Turkish women with gynecological cancer. Asian Pac J Cancer Prev, 15, 2045-9.
  4. Bjelland I, Dahl AA, Haug TT, Neckelmann D (2002). The validity of the hospital anxiety and depression acale. An updated literature review. J Psychosom Res, 52, 69-77.
  5. Bodurka-Bevers D, Basen-Engquist K, Carmack CL, et al (2000). Depression, anxiety, and quality of life in patients with epithelial ovarian cancer. Gynecol Oncol, 78, 302-8.
  6. Cancer Incidence in Five Continents, Vol. X (electronic version) (2014). Eds Forman D, Bray F, Brewster DH, et al. IARC, Lyon. last accessed on November 4.
  7. Chan JK, Urban R, Cheung MK, et al (2006). Ovarian cancer in younger vs older women: a population-based analysis. Br J Cancer, 95, 1314-20.
  8. Clevenger L, Schrepf A, Degeest K, et al (2013). Sleep disturbance, distress, and quality of life in ovarian cancer patients during the first year after diagnosis. Cancer, 119, 3234-41.
  9. Fleming G, Seidman J, Lengyel E (2013). Epithelial ovarian cancer. In Principles and practice of gynecologic oncology 6th ed., Eds Barakat RR, Berchuck A, Markman M, Randall M. Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia pp 757-847.
  10. Harris GM, Allen RS, Dunn L, Parmelee P (2013). "Trouble won't last always": religious coping and meaning in the stress process. Qual Health Res, 23, 773-81.
  11. Hipkins J, Whitworth M, Tarrier N, Jayson G (2004). Social support, anxiety and depression after chemotherapy for ovarian cancer: a prospective study. Br J Health Psychol, 9, 569-81.
  12. Murthy NS, Shalini S, Suman G, Pruthvish S, Mathew A (2009). Changing trends in incidence of ovarian cancer-the Indian scenario. Asian Pac J Cancer Prev, 10, 1025-30.
  13. Nilchaikovit T, Lotrakul M, Phisansuthideth U (1996). Development of Thai version of Hos-pital anxiety and depression scale in cancer patients. J Psychiatr Assoc Thai, 41, 18-30.
  14. Price MA, Bell ML, Sommeijer DW, et al (2013). Physical symptoms, coping styles and quality of life in recurrent ovarian cancer: a prospective population-based study over the last year of life. Gynecol Oncol, 130, 162-8.
  15. Rai B, Bansal A, Patel FD, Sharma SC (2014). Radiotherapy for ovarian cancers-redefining the role. Asian Pac J Cancer Prev, 15, 4759-63.
  16. Ramirez SP, Macedo DS, Sales PM, et al (2012). The relationship between religious coping, psychological distress and quality of life in hemodialysis patients. J Psychosom Res, 72, 129-35.
  17. Reid A, Ercolano E, Schwartz P, McCorkle R (2011). The management of anxiety and knowledge of serum CA-125 after an ovarian cancer diagnosis. Clin J Oncol Nurs, 15, 625-32.
  18. Sharifa Ezat WP, Fuad I, Hayati Y, Zafar A, Wanda Kiyah GA (2014). Observational study on patient's satisfactions and quality of life (QoL) among cancer patients receiving treatment with palliative care intent in a tertiary hospital in Malaysia. Asian Pac J Cancer Prev, 15, 695-701.
  19. Tuncay T (2014). Coping and quality of life in Turkish women living with ovarian cancer. Asian Pac J Cancer Prev, 15, 4005-12.
  20. Wittchen HU, Kessler RC, Beesdo K, et al (2002). Generalized anxiety and depression in primary care: prevalence, recognition and management. J Clin Psychiatry, 63, 24-34.
  21. Zigmond AS, Snaith RP (1983). The hospital anxiety and depression scale. Acta Psychiatr Scand, 67, 361-70.